Novavax handed an extra $147M from legacy Warp Speed program as spotlight shines brighter

It was handed millions to get on with vaccine trials against the virus last year, and now, according to a Securities and Exchange Commission filing, the Operation Warp Speed pact is still handing over cash: The company was given an additional $147.34 million, bringing its total from the program to $1.74 billion.